Stay updated on Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, indicating a minor internal update to the page's metadata or structure rather than content changes to the study details.
    Difference
    0.1%
    Check dated 2026-08-10T12:46:56.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.3 to v3.6.4. This indicates a minor page update without changes to substantive content.
    Difference
    0.1%
    Check dated 2026-07-27T05:49:43.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    Revision updated to v3.6.3, signaling a minor page update. The content and study details remain unchanged.
    Difference
    0.1%
    Check dated 2026-07-05T11:31:08.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page's revision metadata was updated to v3.6.2. The previous revision reference v3.6.0 was removed.
    Difference
    0.1%
    Check dated 2026-06-28T05:08:58.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    Recruitment status on the study page was updated to No longer looking for participants, signaling that enrollment has closed. New help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the Intervention/Treatment label was reformatted, with the revision tag updated to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-13T17:38:54.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.4 to v3.5.5, indicating a minor update to the page's version. The update reflects a metadata/version change rather than changes to study content or eligibility details.
    Difference
    0.1%
    Check dated 2026-06-06T14:16:15.000Z thumbnail image

Stay in the know with updates to Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab & PLD in Platinum Resistant Ovarian Cancer Clinical Trial page.